Similarly, a pilot study in 2015, a clinical trial (randomised) on 42 healthy human participants, receiving oral (tablet form) dosages of BPC 157 was carried out (Clinicaltrials.gov 2018): 0.25, 0.5, 1 and 2 g/kg
Most consumer products containing BPC-157 are labeled as research chemicals and marked as "not for human consumption." These formulations are unregulated and do not comply with manufacturing quality control requirements enforced for dietary supplements
Drug Testing and Analysis, 7(1), 31-38
Its liquid nasal format enables precise volumetric handling for experimental protocols requiring peptide administration via mucosal surfaces or simulation thereof
Overall, further study is needed to understand how the gut microbiota contributes to the neurocognitive advantages of TMA/TMAO in people with MDD
No, the FDA has not approved Glutathione IV treatment